Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01VFQ
|
||||
| Former ID |
DIB009523
|
||||
| Drug Name |
CGEN-855
|
||||
| Synonyms |
CGEN-855; CGEN-855A; CGEN-855B; FPRL1 G-protein-coupled receptor agonists (peptide, inflammation/cardiac disorder); FPRL1 G-protein-coupled receptor agonists (peptide, inflammation/cardiac disorder), Compugen
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [541409] | ||
| Company |
Compugen Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | FMLP receptor | Target Info | Agonist | [543577] | |
| NetPath Pathway | Leptin Signaling Pathway | ||||
| Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
| Reactome | G alpha (i) signalling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.